BD Onclarity™ HPV Assay
The BD Onclarity™ HPV Assay detects 14 high-risk genotypes and provides additional individual results beyond 16 and 18 in a single sample-to-result run, positioning the laboratory to adapt to evolving screening guidelines and to provide timely, comprehensive data to clinicians.
The BD Onclarity™ HPV Assay, which is FDA approved for use with the BD SurePath™ collection vial1, offers genotyping for HPV primary screening, co-testing, and cytology primary with ASCUS reflex screening paradigms.
Pack Size: 192 Tests/Pack
For more information, please visit: